Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Kiora Pharmaceuticals Inc. (KPRX)

Kiora Pharmaceuticals Inc. (KPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Kiora Pharmaceuticals Inc. 169 SAXONY RD. SUITE 212 ENCINITAS CA 92024 USA

www.kiorapharma.com Employees: 13 P: 858-224-9600

Sector:

Medical

Description:

Kiora Pharmaceuticals Inc. is a clinical-stage specialty pharmaceutical company. It involved in developing and commercializing products for treating ophthalmic diseases. The company's product pipeline includes KIO-301, KIO-101 and KIO-201. Kiora Pharmaceuticals Inc., formerly known as EyeGate Pharmaceuticals Inc., is based in SALT LAKE CITY.

Key Statistics

Overview:

Market Capitalization, $K 8,533
Enterprise Value, $K -167
Shares Outstanding, K 3,951
Float, K 3,949
% Float 99.95%
Short Interest, K 16
Short Float 0.40%
Days to Cover 1.00
Short Volume Ratio 0.53
% of Insider Shareholders 0.05%
% of Institutional Shareholders 76.97%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -10,840 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -6,520 K
EBIT, $ -8,210 K
EBITDA, $ -8,190 K

Growth:

1-Year Return -17.35%
3-Year Return -94.22%
5-Year Return -99.86%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 99.59%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.60 on 03/25/26
Next Earnings Date 05/08/26
Earnings Per Share ttm -2.65
EPS Growth vs. Prev Qtr -16,100.00%
EPS Growth vs. Prev Year -53.85%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-9 on 06/11/24

KPRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -51.37%
Return-on-Assets % -36.09%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.44
Book Value/Share 4.38
Interest Coverage -605.00
60-Month Beta -0.78
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.